-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Bluejay Diagnostics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2020 to Q3 2024.
- Bluejay Diagnostics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$1.36M, a 41.8% increase year-over-year.
- Bluejay Diagnostics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$8.07M, a 22.2% increase year-over-year.
- Bluejay Diagnostics, Inc. annual Operating Income (Loss) for 2023 was -$10.3M, a 10.7% decline from 2022.
- Bluejay Diagnostics, Inc. annual Operating Income (Loss) for 2022 was -$9.32M, a 188% decline from 2021.
- Bluejay Diagnostics, Inc. annual Operating Income (Loss) for 2021 was -$3.23M, a 170% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)